Search Results 8311-8320 of 34182 for oral
... Oral and throat cancer, Adenocarcinoma, Laryngeal cancer, Carotid body tumor, Tongue base cancer, Mouth tumor, Salivary gland cancer, Parotid cancer ...
2025. Oral Presentation selected as a Highlight of the Meeting (Hiredesai A, presenter) Annual Meeting Highlights Symposium, American Academy of Orthopaedic ...
ANSWER: In the vast majority of cases like your son's, the cause of hair loss is a condition called androgenic alopecia, or male-pattern baldness. It's usually ...
Treatment was 160 mg of oral zanubrutinib twice daily (n = 50) or 320 mg once daily (n = 23). Efficacy endpoints included overall response rate (ORR) and ...
Able to swallow and retain oral medications and without gastrointestinal (GI) illnesses that would preclude absorption of cediranib or olaparib; Women of ...
Cladribine, mitoxantrone, or oral cyclophosphamide at any time. Treatment with any investigational agent within 24 weeks or 5 drug-elimination half-lives of ...
Requires intermittent or chronic systemic (intravenous or oral) treatment with an antiherpetic drug (eg, acyclovir), other than intermittent topical use ...
Able to swallow oral medication. Both female and male patients of reproductive potential must agree to avoid pregnancy or impregnating a partner ...
Research at Mayo Clinic in diabetic nephropathy includes developing new diagnostic and treatment tools, such as oral medicines that may help stop or delay ...
Mayo Clinic does not endorse companies or products. Advertising revenue supports our not-for-profit mission.
Check out these best-sellers and special offers on books and newsletters from Mayo Clinic Press.
Your donation powers the future of medicine and helps save lives.